Original article
High mite-allergen exposure increases the risk of sensitization in atopic children and young adults

https://doi.org/10.1016/0091-6749(89)90300-XGet rights and content

Abstract

Concentrations of major allergens of Dermatophagoides pteronyssinus (Dpt) and D. farinae (Df), Der p I and Der f I, were determined in 183 dust samples of mattresses of 133 atopic and 50 nonatopic children by a sandwich-type ELISA. Atopic children and young adults living in houses with high levels of Der p I and Der f I (≥2000 ng/gm of dust) were found to have significantly higher serum IgE levels to Dpt and Df (p < 0.0001) compared to patients with low mite-allergen exposure. Washed leukocytes of 55 atopic children and 14 control subjects were investigated for in vitro histamine release to serial dilutions of Der p I; 86% of highly exposed (≥10,000 ng/gm) children demonstrated positive histamine release in response to Der p I compared to 17% in the group with very low exposure (<400 ng/gm). There was a positive correlation between basophil sensitivity (rs = 0.6; p < 0.0001) and reactivity (rs = 0.54; p < 0.0001) to Der p I and mite-allergen exposure. The relative risk for sensitization in the highly exposed group versus the group with very low exposure was sevenfold to 32-fold increased. We conclude that high concentrations of mite allergen (≥2000 ng/gm) increase the risk of specific sensitization in atopic children and young adults and thus may facilitate allergic airway disease.

References (39)

  • U Wahn et al.

    Prospective study on immunologic changes induced by two different Dermatophagoides pteronyssinus extracts prepared from whole mite culture and mite bodies

    J Allergy Clin Immunol

    (1988)
  • LG Arlian et al.

    The prevalence of house dust mites, Dermatophagoides spp. and associated environmental conditions in homes in Ohio

    J Allergy Clin Immunol

    (1982)
  • TAE Platts-Mills et al.

    Reduction of bronchial hyperreactivity during prolonged allergen avoidance

    Lancet

    (1982)
  • S Rowntree et al.

    Development of IgE and IgG antibodies to food and inhalent allergens in children at risk of allergic disease

    Arch Dis Child

    (1985)
  • ER Tovey et al.

    The distribution of dust mite allergen in the houses of patients with asthma

    Am Rev Respir Dis

    (1981)
  • J Korsgaard

    Mite asthma and residency: a case-control study on the impact of exposure to house dust mites in dwellings

    Am Rev Respir Dis

    (1983)
  • A Ishii et al.

    Mite fauna and fungal flora in house dust from homes of asthmatic children

    Allergy

    (1979)
  • GW Wharton

    House dust mites

    J Med Entomol

    (1976)
  • B Schwanz et al.

    Level of indoor allergens in dust from homes of allergic and non-allergic individuals

    Int Arch Allergy Appl Immunol

    (1987)
  • Cited by (333)

    • Environmental Control

      2016, Pediatric Allergy: Principles and Practice: Third Edition
    • Respiratory allergy caused by house dust mites: What do we really know?

      2015, Journal of Allergy and Clinical Immunology
      Citation Excerpt :

      At present, this threshold is not well defined in the literature and is likely to be compounded by the presence of other allergens and some predisposing factors, such as viral infections, exposure to chemicals (eg, formaldehyde), individual susceptibility, and use of medication.22,23 Studies seeking to quantify a level of exposure that can be considered “safe” suggest that levels of less than 2 μg/g of HDM allergens are the maximum level for the primary prevention of sensitization in atopic children and young adults.24,25 A study of HDM sensitization during the first 3 years of life found that sensitization was low during infancy (0.5%), with an increase during the second (1.4%) and third (1.9%) years of life, and concluded that interventions aimed at primary prevention of sensitization should be introduced as early as possible, preferably during infancy.15

    View all citing articles on Scopus

    Supported by the DFG (German Research Foundation Grant Wa 409/5-1).

    From the University Children's Hospital, Berlin, West Germany.

    ∗∗

    From The Protein Laboratory, Copenhagen, Denmark.

    View full text